Cabergoline compared to levodopa in the
✍
Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Högl; Johan
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 128 KB
👁 1 views
## Abstract We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos